Clinical Outcomes Solutions is marking five years in partnership with FingerPost, a leading consultancy providing market-specific payer and Health Technology Assessment (HTA) insights and intelligence.
This long-standing collaboration brings together two expert organisations, one in pricing, market access and reimbursement and the other specialists in COA strategy. The results of this synergy lend value-added support to COS projects through the provision of specific insights relating to Clinical Outcomes Assessment data.
For COS clients, the significant benefit is not only one single point of contact, but also that they are fully informed to consider the regulatory requirements for their COA strategy, as well as the payer and HTA landscape, thereby bolstering understanding for optimal market access.
Meet the team behind the collaboration
Chief Science Officer
Clinical Outcomes Solutions
“Our partnership with FingerPost allows Sponsors access to an even greater level of expertise. The depth of insight that this brings to any COA landscape analysis results in industry leading COA strategies for our clients to utilise in leveraging maximum value to key stakeholders. Like COS, FingerPost has a global reach and, importantly, shares our commitment not only to innovative science, but also in putting the patient at the heart of everything we do.”
“Our partnership with COS has proven highly successful in delivering in depth analyses of Health Technology Assessments (HTA) and the impact of patient-relevant outcomes on reimbursement recommendations and value-based /managed entry agreements across numerous therapeutic areas. The trend of including PRO data in HTA submissions is ever increasing, particularly in oncology, where there are greater expectations from payers to demonstrate the benefits of new therapies beyond overall survival. Our structured and collaborative approach means that clients get the regulatory and market access expertise of two niche agencies, through one contract and one point of contact.”